| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -4.18% | +0.11% | -4.29% | -4.29% | — |
| 14d | 1 | +100.00% | -5.34% | -0.61% | -4.73% | -4.73% | — |
| 30d | 1 | +100.00% | -1.97% | +0.15% | -2.12% | -2.12% | — |
| 60d | 1 | +100.00% | -12.18% | -1.64% | -10.54% | -10.54% | — |
| 90d | 1 | +100.00% | -15.27% | -4.40% | -10.86% | -10.86% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| INCY INCYTE CORP | PURCHASEGRANT Stock grant | 14,237 | — | — | 14,237 | Jan 16, 2026 | Jan 21, 2026 ↗ | View → |
| INCY INCYTE CORP | SALE10b5-1 10b5-1 plan | 10,856 | $109.07 | $1.18M | 66,132 | Jan 7, 2026 | Jan 8, 2026 ↗ | View → |
| INCY INCYTE CORP | SALE EVP, Head of US Oncology | 8,264 | $106.66 | $881.4K | 76,988 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| INCY INCYTE CORP | PURCHASEGRANT Stock grant | 21,923 | — | — | 21,923 | Jul 15, 2025 | Jul 17, 2025 ↗ | View → |
| INCY INCYTE CORP | PURCHASEGRANT Stock grant | 19,735 | — | — | 19,735 | Jul 15, 2025 | Jul 17, 2025 ↗ | View → |
| INCY INCYTE CORP | PURCHASEGRANT Stock grant | 8,769 | — | — | 85,252 | Jul 15, 2025 | Jul 17, 2025 ↗ | View → |
| INCY INCYTE CORP | PURCHASEGRANT Stock grant | 27,812 | — | — | 76,483 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| INCY INCYTE CORP | PURCHASEGRANT Stock grant | 48,671 | — | — | 48,671 | Jan 6, 2025 | Jan 8, 2025 ↗ | View → |